NASDAQ · Healthcare · Biotechnology
Adaptive Biotechnologies Corporation
ADPT
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. CEO Chad Robins · Market cap $4.2B.
$25.99
+0.55 · +2.16%
52w hi $26.1652w lo $12.00
Off 52w high 2.6%
40
ROUTINE
Current InsiderScore
Corp · 90d
4
0 buys · 4 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $24.38
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 18 | Chad M Robins | CEO and Chairman | Sell | 278,472 | $24.48 | −$6.82M | 40 |
| Aug 17 | Peter M Neupert | Sell | 40,000 | $25.10 | −$1.00M | 28 | |
| Aug 17 | Peter M Neupert | Sell | 69,690 | $25.16 | −$1.75M | 32 | |
| Aug 17 | Chad M Robins | CEO and Chairman | Sell | 318,799 | $25.08 | −$8.00M | 40 |
| Apr 06 | Chad M Robins | CEO and Chairman | Sell | 83,332 | $14.41 | −$1.20M | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug